Research published today (FRI) online in The Lancet Infectious Diseases indicates that the vaccine reduces the risk of infection by the parasite that causes severe malaria by 46 per cent over 15 months.
Malaria, which is passed to humans via infected mosquitoes, is one of the biggest killers of children in Africa.
Of the 900,000 people killed by the disease across the continent every year, the majority are children under five.
While the vaccine does not give near total protection, as those for other diseases marketed for use in Western countries typically do, it still has the potential to save large numbers of lives.
This post was read 65 times.